|
US6334997B1
(en)
|
1994-03-25 |
2002-01-01 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
|
KR100477070B1
(ko)
|
1994-03-25 |
2006-04-21 |
이소테크니카 인코포레이티드 |
중수소화작용에의한의약품의효능강화법
|
|
US6534309B1
(en)
|
2000-08-03 |
2003-03-18 |
Cytokinetics, Inc. |
Motor proteins and methods for their use
|
|
AU2002231098A1
(en)
|
2000-12-15 |
2002-06-24 |
Emory University |
Nonpeptide agonists and antagonists of vasopressin receptors
|
|
EP1517904A4
(en)
|
2002-05-23 |
2007-02-21 |
Merck & Co Inc |
INHIBITORS OF MITOTIC KINESINE
|
|
EP2305813A3
(en)
|
2002-11-14 |
2012-03-28 |
Dharmacon, Inc. |
Fuctional and hyperfunctional sirna
|
|
US7423018B2
(en)
|
2002-12-13 |
2008-09-09 |
University Of Massachusetts |
Kinesin-like proteins and methods of use
|
|
US7638549B2
(en)
|
2003-08-15 |
2009-12-29 |
Merck & Co. Inc. |
Mitotic kinesin inhibitors
|
|
US7504413B2
(en)
|
2004-05-06 |
2009-03-17 |
Cytokinetics, Inc. |
N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases
|
|
MXPA06014909A
(es)
|
2004-06-18 |
2007-02-28 |
Chiron Corp |
Derivados de n-(1-(1-bencil -4-fenil-1h -imidazol -2-il)-2, 2-dimetilpropil) benzamida y compuestos relacionados como inhibidores de proteina de huso de cinesina (ksp) para el tratamiento del cancer.
|
|
DE602005024572D1
(de)
|
2004-08-18 |
2010-12-16 |
4Sc Ag |
Benzothienopyridine zur verwendung als inhibitoren von eg5-kinesin
|
|
WO2006114788A1
(en)
|
2005-04-25 |
2006-11-02 |
Ramot At Tel Aviv University Ltd. |
Kinesin polypeptides, polynucleotides encoding same and compositions and methods of using same
|
|
EP1942888A2
(en)
|
2005-11-02 |
2008-07-16 |
Cytokinetics, Inc. |
Certain chemical entities, compositions, and methods
|
|
JP2009543770A
(ja)
|
2006-07-14 |
2009-12-10 |
アステックス・セラピューティクス・リミテッド |
Ｃｄｋ及びｇｓｋの阻害のためのピラゾール誘導体の組合せ剤
|
|
AR062200A1
(es)
|
2006-08-04 |
2008-10-22 |
Aeterna Zentaris Gmbh |
Derivados de antraceno y su uso para el tratamiento de emfermedades tumorales bengnas y malingnas
|
|
US20080051463A1
(en)
|
2006-08-04 |
2008-02-28 |
Aeterna Zentaris Gmbh |
Anthracene compounds and their use for treating benign and malignant tumor disorders
|
|
TW201103904A
(en)
|
2009-06-11 |
2011-02-01 |
Hoffmann La Roche |
Janus kinase inhibitor compounds and methods
|
|
EP2295543A1
(en)
|
2009-09-11 |
2011-03-16 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Method for the preparation of an influenza virus
|
|
WO2011085261A1
(en)
|
2010-01-08 |
2011-07-14 |
Selexagen Therapeutics, Inc. |
Hedgehog inhibitors
|
|
JP5111626B2
(ja)
|
2011-01-14 |
2013-01-09 |
Ｎｔｎ株式会社 |
電動シートリクライニング用ころ軸受
|
|
CN102796103A
(zh)
|
2011-05-23 |
2012-11-28 |
南京英派药业有限公司 |
6-（芳基甲酰）咪唑并[1,2-a]嘧啶和6-（芳基甲酰）[1,2,4]三唑并[4,3-a]嘧啶作为Hedgehog抑制剂及其应用
|
|
US9890430B2
(en)
|
2012-06-12 |
2018-02-13 |
Washington University |
Copy number aberration driven endocrine response gene signature
|
|
JP6098406B2
(ja)
|
2013-07-17 |
2017-03-22 |
Ｊｆｅスチール株式会社 |
溶接接合部および溶接接合方法
|
|
ES2672992T3
(es)
|
2013-08-09 |
2018-06-19 |
Takeda Pharmaceutical Company Limited |
Compuesto aromático
|
|
WO2015183776A1
(en)
|
2014-05-29 |
2015-12-03 |
Merck Sharp & Dohme Corp. |
Methods for treating cancer with a wee1 inhibitor
|
|
EP3233918A1
(en)
|
2014-12-19 |
2017-10-25 |
Novartis AG |
Combination therapies
|
|
WO2016168660A1
(en)
*
|
2015-04-17 |
2016-10-20 |
Forma Therapeutics, Inc. |
3-spiro-7-hydroxamic acid tetralins as hdac inhibitors
|
|
CN106795149B
(zh)
|
2015-05-05 |
2019-09-24 |
上海海雁医药科技有限公司 |
双环取代的苯磺酰胺衍生物、其制法与医药上的用途
|
|
JP6913032B2
(ja)
|
2015-05-20 |
2021-08-04 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
共通ネオ抗原
|
|
SG10202008909VA
(en)
|
2016-03-24 |
2020-10-29 |
Bayer Pharma AG |
Prodrugs of cytotoxic active agents having enzymatically cleavable groups
|
|
US11821042B2
(en)
|
2017-07-10 |
2023-11-21 |
Cornell University |
Targeting chromosomal instability and downstream cytosolic DNA signaling for cancer treatment
|
|
EP3737666A4
(en)
|
2018-01-12 |
2022-01-05 |
Kymera Therapeutics, Inc. |
PROTEIN DEGRADATION AGENTS AND ASSOCIATED USES
|
|
CN108768023B
(zh)
|
2018-08-13 |
2020-01-07 |
珠海格力电器股份有限公司 |
转子组件及交替极电机
|
|
DE102018213662A1
(de)
|
2018-08-14 |
2020-02-20 |
Robert Bosch Gmbh |
Lautsprecher mit einem darin enthaltenen Leuchtelement
|
|
CN109039072B
(zh)
|
2018-08-21 |
2020-09-08 |
南京南瑞继保电气有限公司 |
一种双极双向直流变换器及其控制方法和控制装置
|
|
MA54550A
(fr)
*
|
2018-12-20 |
2022-03-30 |
Amgen Inc |
Inhibiteurs de kif18a
|
|
IL283639B2
(en)
|
2018-12-20 |
2024-06-01 |
Amgen Inc |
Kif18a inhibitors
|
|
AU2019404576B2
(en)
|
2018-12-20 |
2025-07-17 |
Amgen Inc. |
Heteroaryl amides useful as KIF18A inhibitors
|
|
AU2019401495B2
(en)
*
|
2018-12-20 |
2025-06-26 |
Amgen Inc. |
Heteroaryl amides useful as KIF18A inhibitors
|
|
EP3946470A4
(en)
|
2019-04-05 |
2023-05-31 |
Earli Inc. |
IMPROVED METHODS AND COMPOSITIONS FOR SYNTHETIC BIOMARKERS
|
|
KR102449386B1
(ko)
|
2019-05-03 |
2022-10-05 |
주식회사 디시젠 |
암 예후 예측방법 및 이의 조성물
|
|
US20230093080A1
(en)
|
2019-07-15 |
2023-03-23 |
Kymera Therapeutics, Inc. |
Protein degraders and uses thereof
|
|
US20220289724A1
(en)
|
2019-08-02 |
2022-09-15 |
Amgen Inc. |
Kif18a inhibitors
|
|
MX428368B
(es)
|
2019-08-02 |
2025-11-13 |
Amgen Inc |
Inhibidores de kif18a
|
|
JP7699100B2
(ja)
|
2019-08-02 |
2025-06-26 |
アムジエン・インコーポレーテツド |
Ｋｉｆ１８ａ阻害剤
|
|
AU2020325115B2
(en)
*
|
2019-08-02 |
2026-03-12 |
Amgen Inc. |
Pyridine derivatives as KIF18A inhibitors
|
|
EP4103045A4
(en)
|
2020-02-16 |
2024-08-14 |
Genetikaplus Ltd. |
Methods of therapeutic prognostication
|
|
US12187992B2
(en)
|
2020-02-19 |
2025-01-07 |
The Regents Of The University Of California |
Method and device for early cancer screening
|
|
JP2023521802A
(ja)
|
2020-04-14 |
2023-05-25 |
アムジエン・インコーポレーテツド |
新生物疾患の処置のためのｋｉｆ１８ａ阻害剤
|
|
WO2021231413A1
(en)
|
2020-05-11 |
2021-11-18 |
University Of Vermont |
A treatment approach involving kif18a inhibition for chromosomally unstable tumors
|
|
TW202220958A
(zh)
|
2020-08-07 |
2022-06-01 |
美商卡司馬療法公司 |
Ｔｒｐｍｌ調節劑
|
|
EP4319821A4
(en)
|
2021-04-09 |
2026-05-06 |
Nanjing University |
CONJUGATE AND ITS PREPARATION PROCESS AND ITS USE
|
|
CN113528509A
(zh)
|
2021-06-01 |
2021-10-22 |
释科生物科技(广州)有限公司 |
一种用于预测胃癌免疫治疗的肿瘤微环境评分系统的构建方法以及分子探针
|
|
EP4361142A4
(en)
|
2021-06-25 |
2025-07-09 |
Hangzhou Innogate Pharma Co Ltd |
COMPOUND FOR USE AS A KIF18A INHIBITOR
|
|
TW202321213A
(zh)
|
2021-07-21 |
2023-06-01 |
美商安進公司 |
Ｋｉｆ１８ａ抑制劑化合物之鹽和固態形式
|
|
CN115772159A
(zh)
|
2021-09-06 |
2023-03-10 |
微境生物医药科技(上海)有限公司 |
Kif18a抑制剂
|
|
CN115785068A
(zh)
|
2021-09-10 |
2023-03-14 |
微境生物医药科技(上海)有限公司 |
Kif18a抑制剂
|
|
CN118076586A
(zh)
|
2021-09-16 |
2024-05-24 |
微境生物医药科技(上海)有限公司 |
Kif18a抑制剂
|
|
US20230117405A1
(en)
|
2021-09-22 |
2023-04-20 |
Volastra Therapeutics, Inc. |
Systems and methods for evaluation of chromosomal instability using machine-learning
|
|
MX2024005996A
(es)
|
2021-11-19 |
2024-05-30 |
Wigen Biomedicine Tech Shanghai Co Ltd |
Inhibidor de kif18a.
|
|
AU2023261964A1
(en)
|
2022-04-28 |
2024-11-07 |
Volastra Therapeutics, Inc. |
Compounds for inhibiting kif18a
|